Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mick Bhatia

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
The Journal of Experimental Medicine|December 16, 2015
Hypoxia factors suffocate leukemic stem cell initiationMick Bhatia
Neurotoxicology|June 17, 2026
Human blood-derived neural progenitor cells as a platform for developmental neurotoxicity of micro- and nanoplasticsKinga Vojnits, Jad Kaj, Kelly Rees, et al.
Molecules (Basel, Switzerland)|April 23, 2022
Developing CRISPR/Cas9-Mediated Fluorescent Reporter Human Pluripotent Stem-Cell Lines for High-Content ScreeningKinga Vojnits, Mio Nakanishi, Deanna Porras, et al.
Cancer Letters|July 10, 2024
Targeting of human cancer stem cells predicts efficacy and toxicity of FDA-approved oncology drugsKinga Vojnits, Zhuohang Feng, Paige Johnson, et al.
Oncotarget|June 18, 2015
Neoplastic human embryonic stem cells as a model of radiation resistance of human cancer stem cellsSteve Dingwall, Jung Bok Lee, Borhane Guezguez, et al.
Stem Cells and Development|July 26, 2012
Lengthened G1 phase indicates differentiation status in human embryonic stem cellsAshley Calder, Ivana Roth-Albin, Sonam Bhatia, et al.
Cell Reports|August 17, 2022
Induced pluripotent stem cells display a distinct set of MHC I-associated peptides shared by human cancersAnca Apavaloaei, Leslie Hesnard, Marie-Pierre Hardy, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
The Journal of Experimental Medicine|December 16, 2015
Hypoxia factors suffocate leukemic stem cell initiationMick Bhatia
Neurotoxicology|June 17, 2026
Human blood-derived neural progenitor cells as a platform for developmental neurotoxicity of micro- and nanoplasticsKinga Vojnits, Jad Kaj, Kelly Rees, et al.
Molecules (Basel, Switzerland)|April 23, 2022
Developing CRISPR/Cas9-Mediated Fluorescent Reporter Human Pluripotent Stem-Cell Lines for High-Content ScreeningKinga Vojnits, Mio Nakanishi, Deanna Porras, et al.
Cancer Letters|July 10, 2024
Targeting of human cancer stem cells predicts efficacy and toxicity of FDA-approved oncology drugsKinga Vojnits, Zhuohang Feng, Paige Johnson, et al.
Oncotarget|June 18, 2015
Neoplastic human embryonic stem cells as a model of radiation resistance of human cancer stem cellsSteve Dingwall, Jung Bok Lee, Borhane Guezguez, et al.
Stem Cells and Development|July 26, 2012
Lengthened G1 phase indicates differentiation status in human embryonic stem cellsAshley Calder, Ivana Roth-Albin, Sonam Bhatia, et al.
Cell Reports|August 17, 2022
Induced pluripotent stem cells display a distinct set of MHC I-associated peptides shared by human cancersAnca Apavaloaei, Leslie Hesnard, Marie-Pierre Hardy, et al.
Pageof 1